BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24502865)

  • 21. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A qualititative study of neurological soft signs in obsessive compulsive disorder and effect of comorbid psychotic spectrum disorders and familiality on its expression in Indian population.
    Malhotra DS; Borade DP; Sharma DP; Satija DY; Dr Gunjan
    Asian J Psychiatr; 2017 Feb; 25():6-12. PubMed ID: 28262175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is familial obsessive-compulsive disorder different from sporadic obsessive-compulsive disorder? A comparison of clinical characteristics, comorbidity and treatment response.
    Viswanath B; Narayanaswamy JC; Cherian AV; Reddy YC; Math SB
    Psychopathology; 2011; 44(2):83-9. PubMed ID: 21196809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both.
    Centorrino F; Hennen J; Mallya G; Egli S; Clark T; Baldessarini RJ
    Hum Psychopharmacol; 2006 Apr; 21(3):189-93. PubMed ID: 16625524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifetime comorbidity of obsessive-compulsive disorder and sub-threshold obsessive-compulsive symptomatology in the community: impact, prevalence, socio-demographic and clinical characteristics.
    Fineberg NA; Hengartner MP; Bergbaum C; Gale T; Rössler W; Angst J
    Int J Psychiatry Clin Pract; 2013 Aug; 17(3):188-96. PubMed ID: 23428236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities?
    Storch EA; Lewin AB; Farrell L; Aldea MA; Reid J; Geffken GR; Murphy TK
    J Anxiety Disord; 2010 Aug; 24(6):547-52. PubMed ID: 20399603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study of telephone cognitive-behavioural therapy for obsessive-compulsive disorder in young people.
    Turner C; Heyman I; Futh A; Lovell K
    Behav Cogn Psychother; 2009 Jul; 37(4):469-74. PubMed ID: 19545482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive-behavioral therapy for obsessive-compulsive disorder as a comorbidity with schizophrenia or schizoaffective disorder.
    Tundo A; Salvati L; Di Spigno D; Cieri L; Parena A; Necci R; Sciortino S
    Psychother Psychosom; 2012; 81(1):58-60. PubMed ID: 22123432
    [No Abstract]   [Full Text] [Related]  

  • 31. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder.
    Carter AS; Pollock RA; Suvak MK; Pauls DL
    Depress Anxiety; 2004; 20(4):165-74. PubMed ID: 15643633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: The clinic-based prevalence rate, symptoms nature and clinical correlates.
    Jeon S; Baek JH; Yang SY; Choi Y; Ahn SW; Ha K; Hong KS
    J Affect Disord; 2018 Jan; 225():227-233. PubMed ID: 28841485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidity of obsessive-compulsive and psychotic symptoms: a review.
    Dowling FG; Pato MT; Pato CN
    Harv Rev Psychiatry; 1995; 3(2):75-83. PubMed ID: 9384932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopathological and peripheral levels of neurobiological correlates of obsessive-compulsive symptoms in patients with epilepsy: a hospital-based study.
    Hamed SA; Elserogy YM; Abd-Elhafeez HA
    Epilepsy Behav; 2013 May; 27(2):409-15. PubMed ID: 23541859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    Jacobsen FM
    J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obsessive-compulsive disorder in postmenopausal women: prevalence, clinical features, and comorbidity.
    Uguz F; Sahingoz M; Gezginc K; Karatayli R
    Aust N Z J Psychiatry; 2010 Feb; 44(2):183-7. PubMed ID: 20113307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A NATURALISTIC EXPLORATORY STUDY OF OBSESSIVE-COMPULSIVE BIPOLAR COMORBIDITY IN YOUTH.
    Masi G; Berloffa S; Mucci M; Pfanner C; D'Acunto G; Lenzi F; Liboni F; Manfredi A; Milone A
    J Affect Disord; 2018 Apr; 231():21-26. PubMed ID: 29408159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obsessive-compulsive Disorder with Comorbid Bipolar Disorders: Clinical Features and Treatment Implications.
    Mucci F; Toni C; Favaretto E; Vannucchi G; Marazziti D; Perugi G
    Curr Med Chem; 2018; 25(41):5722-5730. PubMed ID: 29119914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance therapy with electroconvulsive therapy in a patient with a codiagnosis of bipolar disorder and obsessive-compulsive disorder.
    Bülbül F; Copoglu US; Alpak G; Unal A; Tastan MF; Savas HA
    J ECT; 2013 Jun; 29(2):e21-2. PubMed ID: 23519221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lifetime comorbidity of obsessive-compulsive disorder with psychiatric disorders in a community sample.
    Mohammadi MR; Ghanizadeh A; Moini R
    Depress Anxiety; 2007; 24(8):602-7. PubMed ID: 17152061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.